.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Abstractvortrag

Repurposing the anti-cancer potential of Brefeldin A for the treatment of MYC-driven cancers

Appointment

Date: 27/10/2022

Time: 13:45 – 14:00

Talk time: 10 Min.

Discussion time: 5 Min.

Location / Stream:

Saal C/D

Session

Experimentelle Neuroonkologie

Authors

Thomas Beez (Düsseldorf), Johanna Louise Trübel (Düsseldorf), Daniel Picard (Düsseldorf), Nan Qin (Düsseldorf), Marc Remke (Düsseldorf), Ute Fischer (Düsseldorf), David Pauck (Düsseldorf), Guido Reifenberger (Düsseldorf), Lena Blümel (Düsseldorf), Marlene Vogt (Düsseldorf), Vanessa Augstein (Düsseldorf)